Open main menu

Psychiatrienet β

Difference between revisions of "Trazodone-amitriptyline"

 
(One intermediate revision by one other user not shown)
Line 3: Line 3:
 
| to = amitriptyline  
 
| to = amitriptyline  
 
| stop =  
 
| stop =  
* '''Before day 1:''' gradually reduce dosage of trazodone to a maximum of 150 mg/day, when this dosage is > 150 mg/day.
+
{{TCAdecrease25p3d}}
* '''Day 1:''' reduce dosage of trazodone to 75-100 mg/day.
 
* '''Day 8:''' stop administration of trazodone.
 
 
| start =  
 
| start =  
No wash-out period is needed.
+
{{TCAincrease25p3d}}
* '''Day 1:''' simultaneously start administration of amitriptyline in a dosage of 25 mg/day.
+
| info =
* '''Day 8:''' continue administration of amitriptyline in a dosage of 50 mg/day.
+
{{TCAplasmalevelmonitoring}}
* Start low, go slow.
+
}}
| info =  
 
* The content of trazodone in the tablet, for example 100 mg or 150 mg, determines which exact doses are given.
 
{{review}} }}
 

Latest revision as of 13:17, 30 June 2023

Trazodone
Type Antidepressant
Group other
links
Medscape Trazodone
PubChem 5533
PubMed Trazodone
Kompas (Dutch) Trazodone
Wikipedia Trazodone
Amitriptyline
Type Antidepressant
Group TCA
links
ATC-code N06AA09
Medscape Amitriptyline
PubChem 2160
PubMed Amitriptyline
Kompas (Dutch) Amitriptyline
Wikipedia Amitriptyline

Switch medication from trazodone to amitriptyline.[1] [2]

Nietinrijdenbord.png Stop trazodone
  • Day 1: Decrease with about 25% of the original dose per 3 days.
Eenrichtingbord.png Start amitriptyline
  • Day 1: Increase with about 25% of target dose per 3 days.
Infobord.png More information
  • Plasma monitoring for TCA's is advisable, because of plasma-reponse relations, genetic polymorphism and under or overdosing.[3]
  1. Switches are based on literature references on this page and expert opinions of the authors. The authors have used pharmacokinetic and receptor affinity properties to determine the switch schedules
  2. Stahl, S. M. (2013). Stahl's essential psychopharmacology: Neuroscientific basis and practical applications (4th ed.). Cambridge University Press.
  3. (dutch) monografie.org tricyclische-antidepressiva
The editors of psychiatrienet.nl take the greatest care to provide up-to-date and accurate information on this site. Nevertheless, mistakes and omissions cannot be entirely excluded. No rights devolve from the information provided. The editors and other providers of information to this site accept no responsibility for the content of this site or for the information provided therein; neither do they accept responsibility for possible damages which may derive from the use of the information on this site or from the linked sites. The editorial board accepts no responsibility for the content of the (linked) sites, for access to them, or for the products and services on these sites, nor for the occurrence of errors, viruses, and/or disruptions in service.